Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cross tolerance between mescaline and LSD-25, with a comparison of the mescaline and LSD reactions.

Literature DB >> 14007904

Cross tolerance between mescaline and LSD-25, with a comparison of the mescaline and LSD reactions.

A B WOLBACH, H ISBELL, E J MINER.

Abstract

Keywords: LYSERGIC ACID DIETHYLAMIDE/pharmacology; MERCURY/pharmacology

Mesh：

Substances：

Year: 1962 PMID： 14007904 DOI： 10.1007/BF00413101

Source DB: PubMed Journal: Psychopharmacologia

× No keyword cloud information.

12 in total

1. Cross tolerance between LSD and psilocybin.

Authors: H ISBELL; A B WOLBACH; A WIKLER; E J MINER
Journal: Psychopharmacologia Date: 1961

2. Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148.

Authors: A BALESTRIERI; D FONTANARI
Journal: AMA Arch Gen Psychiatry Date: 1959-09

3. Comparison of the reactions induced by psilocybin and LSD-25 in man.

Authors: H ISBELL
Journal: Psychopharmacologia Date: 1959

4. Patterns of tolerance to lysergic acid diethylamide and mescaline in rats.

Authors: D X FREEDMAN; G K AGHAJANIAN; E M ORNITZ
Journal: Science Date: 1958-05-16 Impact factor: 47.728

5. Bioassays and mathematics.

Authors: J H GADDUM
Journal: Pharmacol Rev Date: 1953-03 Impact factor: 25.468

6. Effects of mescaline and lysergic acid (d-LSD-25).

Authors: P H HOCH; J P CATTELL; H H PENNES
Journal: Am J Psychiatry Date: 1952-02 Impact factor: 18.112

7. Experimental schizophrenia-like symptoms.

Authors: M RINKEL; H J DeSHON; R W HYDE; H C SOLOMON
Journal: Am J Psychiatry Date: 1952-02 Impact factor: 18.112

8. The estimation of amines in biological materials with critical data for cocaine and mescaline.

Authors: L A WOODS; J COCHIN; E J FORNEFELD; F G McMAHON; M H SEEVERS
Journal: J Pharmacol Exp Ther Date: 1951-02 Impact factor: 4.030

9. Experimental psychoses and other mental abnormalities produced by drugs.

Authors: W MAYER-GROSS
Journal: Br Med J Date: 1951-08-11

10. Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication.

Authors: R E BELLEVILLE; H F FRASER; H ISBELL; C R LOGAN; A WIKLER
Journal: AMA Arch Neurol Psychiatry Date: 1956-11

19 in total

4. On the interaction of drugs with the cholinergic nervous system. II. Cross-tolerance between phencyclidine derivatives and cholinergic drugs.

Authors: I Pinchasi; S Maayani; Y Egozi; M Sokolovsky
Journal: Psychopharmacology (Berl) Date: 1978-01-31 Impact factor: 4.530

Cross tolerance between mescaline and LSD-25, with a comparison of the mescaline and LSD reactions.

1. Cross tolerance between LSD and psilocybin.

2. Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148.

3. Comparison of the reactions induced by psilocybin and LSD-25 in man.

4. Patterns of tolerance to lysergic acid diethylamide and mescaline in rats.

5. Bioassays and mathematics.

6. Effects of mescaline and lysergic acid (d-LSD-25).

7. Experimental schizophrenia-like symptoms.

8. The estimation of amines in biological materials with critical data for cocaine and mescaline.

9. Experimental psychoses and other mental abnormalities produced by drugs.

10. Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication.

1. THE EFFECT OF N,N-DIMETHYLTRYPTAMINE IN HUMAN SUBJECTS TOLERANT TO LYSERGIC ACID DIETHYLAMIDE.

2. Comparison of psilocin with psilocybin, mescaline and LSD-25.

Review 3. Human hallucinogen research: guidelines for safety.

4. On the interaction of drugs with the cholinergic nervous system. II. Cross-tolerance between phencyclidine derivatives and cholinergic drugs.

5. Effect of chronic treatment with mescaline upon tissue levels of the drug.

6. Interpretation of visual space under drug-induced ergotropic and trophotropic arousal.

7. Psilocybin-induced contraction of nearby visual space.

8. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.

Review 9. The psychopharmacology of "cannabis sativa": a review.

Review 10. Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.